Skip to main content

NCI at ASCO Virtual Education Program

The National Cancer Institute (NCI) will be participating in the American Society of Clinical Oncology (ASCO) Virtual Education Program, to be held August 8-10.

Registration is free for ASCO members. Non-members who register will also gain access to on-demand content from the Virtual Scientific Program held in May. Register now and view the program for a full list of available presentations.

Subscribe to stay updated on the latest abstracts, presentations, and resources from NCI at ASCO20 and future meetings.

NCI Leadership Presentation

Join NCI Director, Norman E. Sharpless, MD, as he participates in a panel discussion with ASCO leaders, Cliff Hudis, MD and Skip Burris, MD. Dr. Sharpless will explain the flexibilities NCI granted to clinical trials during the COVID-19 pandemic and highlight how the lessons learned will support future cancer research and effective patient care.
 
Join this panel during the Opening Session Saturday, August 8, 8:30-10:00 a.m. EDT

Presentations Featuring NCI Experts

Stephanie L. Goff, MD, FACS

Associate Research Physician in NCI’s Surgery Branch, Dr. Stephanie Goff, will give her presentation, “Killer T’s: The History and Future of Cell Therapy.” Dr. Goff’s presentation will discuss immunotherapy beyond checkpoints in melanoma – highlighting the utilization of Tumor Infiltrating Lymphocytes (TIL) for brain metastases and melanoma, as well as going beyond TIL for melanoma treatment.

Join this session Monday, August 10, 10:00-11:00 a.m. EDT

Tony Dickherber, PhD

NCI program director, Dr. Tony Dickherber, will give a presentation on the emerging landscape of liquid biopsy technologies in the session on “Chasing Sarcoma in the Blood: Circulating Tumor Cells and DNA.”  Dr. Dickherber will discuss the commercial landscape for available platforms and approaches, persistent technical challenges that hamper their adoption, and emerging technologies that NCI has supported addressing those challenges. In addition, he will discuss the important role clinician scientists can and should play in accelerating the incorporation of liquid biopsies into clinical trials with sarcoma patients.

Join this session Sunday, August 9, 9:00-10:00 a.m. EDT

Funding Opportunities Available

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “NCI at ASCO Virtual Education Program was originally published by the National Cancer Institute.”